Phibro Animal Health (NASDAQ:PAHC) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Phibro Animal Health (NASDAQ:PAHC) released its quarterly earnings data on Wednesday. The company reported $0.79 EPS for the quarter, beating the consensus estimate of $0.78 by $0.01, FiscalAI reports. Phibro Animal Health had a return on equity of 37.86% and a net margin of 6.57%. The firm had revenue of $386.77 million during the quarter, compared to the consensus estimate of $382.42 million.

Phibro Animal Health Stock Up 4.7%

NASDAQ PAHC traded up $1.78 during trading hours on Wednesday, hitting $39.43. The company’s stock had a trading volume of 266,659 shares, compared to its average volume of 281,937. Phibro Animal Health has a 52 week low of $28.25 and a 52 week high of $60.08. The company has a market capitalization of $1.60 billion, a PE ratio of 16.16 and a beta of 0.42. The company has a current ratio of 2.96, a quick ratio of 1.27 and a debt-to-equity ratio of 1.84. The company’s 50-day simple moving average is $37.16 and its two-hundred day simple moving average is $41.09.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 16th. Investors of record on Wednesday, November 25th will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, November 25th. This represents a $0.48 annualized dividend and a yield of 1.2%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 19.67%.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 18th. Weiss Ratings upgraded shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, Phibro Animal Health currently has an average rating of “Buy” and a consensus target price of $47.67.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.